Vicente Reynal
Director Since: 2022
Committees: Finance (Chair); Compensation
Mr. Reynal contributes significant global leadership and operational experience, including expertise in corporate transactions, customer service and brand loyalty strategies. He oversaw growth and profitability leading to the IPO of Gardner Denver in 2017 and its subsequent acquisition by Ingersoll Rand, delivering significant stockholder value. His deep insights into transformative growth strategies inform the Board’s discussions focused on growth initiatives
and risk oversight.
Career highlights
Ingersoll Rand Inc. (NYSE: IR)—a global manufacturing technology company
▪ Chairman (2021-Present)
▪ President and Chief Executive Officer (2020-Present)
Gardner Denver Inc. (NYSE: GDI)—an industrial manufacturing company
(merged with Ingersoll Rand in 2020)
▪ Chief Executive Officer and President (2017-2020)
▪ Chief Executive Officer and President, Industrials (2015-2016)
Danaher Corporation (NYSE: DHR)—a global life science and manufacturing
company
▪ Group President, Dental Technologies (2014-2015)
▪ President, Ormco (2011-2013)
▪ President, Pelton & Crane, KaVo and Dental Platform Special Markets
(2007-2011)
▪ Vice President, Global Operations (2004-2007)
Thermo Fisher Scientific (NYSE: TMO)—a life sciences and scientific
instruments company
▪ Vice President, Global Operations and Supply Chain (2002-2004)
Allied Signal Aerospace (Honeywell Aero today)
▪ Business Unit Manager (Engine Repair and Overhaul) (1998-2002)
Board committees
▪ Finance (Chair), Compensation
Education
▪ BS, Mechanical Engineering, Georgia Institute of Technology
▪ MS, Mechanical Engineering, MIT
▪ MS, Technology & Policy, MIT
Current public company directorships
▪ Ingersoll Rand Inc. (NYSE: IR) (2020-Present)
Past public company directorships
▪ Gardner Denver Inc. (NYSE: IR) (2017-2020)
Notable affiliations
▪ Board Member, Ownership Works
▪ Board Member, American Heart Association